These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Significance of CEA and CA 19-9 for after care of curatively resected colorectal cancers]. Stapel A, Franke U, Putzki H. Zentralbl Chir; 1992; 117(2):77-80. PubMed ID: 1315472 [Abstract] [Full Text] [Related]
3. Tumor markers in patients with relapse of colorectal carcinoma. Lipská L, Visokai V, Levý M, Svobodová S, Kormunda S, Fínek J. Anticancer Res; 2007; 27(4A):1901-5. PubMed ID: 17649792 [Abstract] [Full Text] [Related]
13. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer. Griesenberg D, Nürnberg R, Bahlo M, Klapdor R. Anticancer Res; 1999 Sep; 19(4A):2443-50. PubMed ID: 10470173 [Abstract] [Full Text] [Related]
14. Circulating cancer cells: could they be used in the clinic as recurrence markers for gastric and colorectal cancer? Hanisch E, Hottenrott C, Roukos DH. Ann Surg Oncol; 2009 Mar; 16(3):778-9; author reply 780-2. PubMed ID: 19116754 [No Abstract] [Full Text] [Related]